Ms. Rachel Lavine is Non-Executive Vice Chairman of the Board at ATRIUM EUROPEAN REAL ESTATE LIMITED since December 1, 2014. Previously, she was Executive Vice Chairman since November 30, 2014. She has been Chief …
If you want a Stock Review on IART, ATRS, BDX, or WAT then come over to http://dailystocktracker.com/register and …
If you want a Stock Review on ATRS, IART, BDX, or WAT then come over to http://dailystocktracker.com/register/ and …
In keeping with the commitment to dynamically provide members with timely information, WallStEquities.com has …
Jersey, 9 February 2018: Atrium European Real Estate Limited (VSE/Euronext: ATRS), ("Atrium" or the "Company" and …
ATRS closed Thursday's trading at $3.73, down 5.33%. In after-hours, the stock was down 41.02% to $2.20. BioDelivery Sciences International Inc. (BDSI) has entered into a Settlement Agreement with Teva Pharmaceuticals Industries Ltd. …
and they also are very bullish on a mega-cap technology stock and a small-cap biotech. All are rated Buy at Jefferies. This small-cap biotech may prove to be a big-time winner for aggressive accounts. Antares Pharma Inc. (NASDAQ: ATRS) …
A year ago, they were trading at $1.53. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS